Ioannis Stathopoulos - Owner - Energyplanning | LinkedIn
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment | Blood Cancer Journal
Ioannis Stathopoulos - Owner - Energyplanning | LinkedIn
Ioannis Stathopoulos - Owner - Energyplanning | LinkedIn
Konstantinos Stathopoulos - Project Manager - EPIRUS SA – ΗΠΕΙΡΟΣ ΑΕΒΕ | LinkedIn
Spiros Stathopoulos - Civil Engineer - ETHNOKAT | LinkedIn
Ioannis Stathopoulos - Owner - Energyplanning | LinkedIn
Microorganisms | Free Full-Text | Anti–SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study
Yannis Stathopoulos - Cloud Technology Strategist - Microsoft | LinkedIn
Ioannis Stathopoulos - Owner - Energyplanning | LinkedIn
Cancers | Free Full-Text | A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma | HTML
7 "Yannis Stathopoulos" profiles | LinkedIn
PDF) A Molecular Signature of Circulating MicroRNA Can Predict Osteolytic Bone Disease in Multiple Myeloma
Panagiotis Stathopoulos - Senior Solutions Architect - UniSystems | LinkedIn
Obesity and Risk for Brain/CNS Tumors, Gliomas and Meningiomas: A Meta-Analysis
Obesity and Risk for Brain/CNS Tumors, Gliomas and Meningiomas: A Meta-Analysis
Ioannis Stathopoulos - Owner - Energyplanning | LinkedIn
30+ "Ioannis Anagnostopoulos" profiles | LinkedIn
Nikolaos Stathopoulos - Postdoctoral Associate - National Center for Scientific Research "Demokritos" | LinkedIn
JCM | Free Full-Text | Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction | HTML
Ioannis Stathopoulos died
Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis: Amyloid: Vol 28, No 1
JCM | Free Full-Text | Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World “POWERFUL” Study
Dimitris Stathopoulos - BSS Technology Application Management & Support Manager at Coca-Cola Hellenic Bottling Company - Coca-Cola Hellenic Bottling Company | LinkedIn
CD38: targeted therapy in multiple myeloma and therapeutic potential for solid cancers: Expert Opinion on Investigational Drugs: Vol 29, No 11
